NCT03940950View on ClinicalTrials.gov

Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 2, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Osteo Arthritis KneeDegenerative Joint Disease of Knee
Interventions
BIOLOGICAL

Autologous Adipose-Derived SVF (Stromal Vascular Fraction)

60 ml of fat is collected from subjects abdominal wall and SVF is removed from the fat. The SVF is injected into the knee through a needle.

DRUG

Placebo

Saline control that contains no active ingredient

Trial Locations (1)

32224

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03940950 - Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter